FRANCESCA HECTOR: Open Payments
NPI 1013682491 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,031 in 93 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $2,611 · 2025 $3,031
Food & beverage: $2,462Travel & lodging: $562Education: $7
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 31 | $1,598 |
| Novo Nordisk Inc | 11 | $248 |
| Amphastar Pharmaceuticals, Inc. | 7 | $158 |
| Xeris Pharmaceuticals, Inc. | 8 | $151 |
| RECORDATI_RARE_DISEASES_INC. | 7 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $114 |
| Dexcom, Inc. | 2 | $93 |
| Lilly USA, LLC | 4 | $90 |
| SANOFI-AVENTIS U.S. LLC | 2 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
Products named: MINIMED 780G, JARDIANCE, RECORLEV, ISTURISA, Ozempic, Dexcom G6 Transmitter, TZIELD, Kerendia.
Industry payments across PA — which companies pay providers there.
